Since its inception in 2010, the FDA s Tobacco Products Scientific Advisory Committee (TPSAC) has been populated by highly conflicted experts. Although it s powerless, still some rules need following. Federal Judge Leon agrees; FDA s Zeller does not.
FDA
FDA bans marketing of testosterone for non-specific symptoms, concerned about possible heart effects
FDA pulls rug out from under low-T therapy: testosterone prescriptions can no longer be given for vague symptoms more consistent with aging than with actual illness.
Carrier screening is a type of genetic testing performed on couples that are expecting or planning to have children to see if they may be at risk for passing a genetic disorder on to
The latest in health news: long-lasting GM apples win the fight, while GMO labeling adds confusion for consumers, and added vitamins to foods does not make you eat a poor diet, despite what a NYTimes op-ed says.
Last month, the European Food Safety Authority (EFSA) weighed in on bisphenol A (BPA), saying exactly what we ve said all along, BPA poses no health risk to
According to the Centers for Disease Control and Prevention (CDC), more than a third of U.S. adults are obese. Bariatric surgery in which either an inflatable band is placed around the stomach to reduce stomach size or in which the stomach and part of the small intestine are bypassed is perhaps the most effective means of
Caffeine, a naturally occurring ingredient found in coffee and tea, has also been added of late to everything from energy drinks to candy. Now, it is even being sold as pure caffeine in powder form, a teaspoon of which is equivalent to 25 cups of coffee. This powder can be purchased online or in stores that sell supplements and may
This past year, several states have had plebiscites on whether or not to require that foods containing genetically engineered (GMO) ingredients be labeled. All but one of those measures were defeated: in California, Washington, Colorado and now, officially, Oregon. Vermont voters approved a labeling measure,
On Wednesday, the U.S. Department of Health and Human Services (DHHS) proposed a plan to significantly increase the information reported on clinical trials related to drugs, devices, and other interventions. The proposed plan would apply to the National Institutes of Health (NIH) publicly accessible database, ClinicalTrials.gov.
ACSH S Dr. Gil Ross was quoted in the Washington Examiner yesterday in an article dealing with a House committee member s concerns about the FDA and the USDA s approach to handling evaluations and reporting on pesticide residues on food. His opinion differed from a rep. from the Pesticide Action Network, as you would imagine.
In his recent opinion piece published in the New York Post, ACSH friend and former trustee (and former FDA official) Dr. Henry Miller questions the FDA s decision to grant permission for expanded access to
Concussions are a major concern among athletes and it is imperative that individuals receive appropriate medical attention in the event of a